Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.8M Sell
130,177
-6,551
-5% -$1.41M 1.65% 6
2026
Q1
$29.7M Buy
136,728
+10,813
+9% +$2.4M 1.61% 7
2025
Q4
$28.8M Sell
125,915
-9,074
-7% -$2.07M 1.57% 10
2025
Q3
$31.3M Sell
134,989
-74,746
-36% -$15.2M 1.85% 8
2025
Q2
$38.9M Sell
209,735
-19,432
-8% -$3.61M 2.77% 5
2025
Q1
$48M Buy
229,167
+61,794
+37% +$12M 3.8% 4
2024
Q4
$29.7M Sell
167,373
-38,086
-19% -$7M 2.38% 6
2024
Q3
$40.6M Buy
205,459
+72,207
+54% +$13.5M 3.16% 4
2024
Q2
$22.9M Sell
133,252
-27,995
-17% -$4.64M 2.1% 7
2024
Q1
$29.4M Sell
161,247
-1,544
-0.9% -$266K 2.52% 5
2023
Q4
$25.2M Sell
162,791
-17,328
-10% -$2.53M 2.12% 6
2023
Q3
$26.8M Sell
180,119
-23,033
-11% -$3.38M 2.32% 5
2023
Q2
$27.4M Buy
203,152
+42,715
+27% +$6.26M 2.22% 4
2023
Q1
$25.6M Sell
160,437
-37,732
-19% -$5.77M 2.36% 3
2022
Q4
$32M Sell
198,169
-31,522
-14% -$4.83M 2.77% 5
2022
Q3
$30.8M Buy
229,691
+128,412
+127% +$18.4M 3.06% 5
2022
Q2
$15.5M Buy
101,279
+77,950
+334% +$11.9M 1.56% 8
2022
Q1
$3.78M Sell
23,329
-3,895
-14% -$566K 0.33% 93
2021
Q4
$3.69M Buy
+27,224
New +$3.22M 0.27% 110
2019
Q1
Sell
-1,371,271
Closed -$126M 218
2018
Q4
$126M Buy
+1,371,271
New +$121M 9.19% 2

Other funds holding ABBV

Sepio Capital's ABBV Position: Q2 2026 in Review

Sepio Capital reduced its AbbVie (ABBV) stake by 4.8% in Q2 2026, selling an estimated $1.41M and leaving 130,177 shares worth $32.8M. The position accounts for 1.65% of the portfolio, ranked #6.

Sepio Capital first reported a position in ABBV in Q4 2018 and has held it in 20 quarters since. The position peaked at $126M in Q4 2018. 2,043 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sepio Capital held 130,177 shares of AbbVie worth $32.8M as of Q2 2026.
  • Sepio Capital sold 6,551 AbbVie shares in Q2 2026, an estimated $1.41M.
  • AbbVie made up 1.65% of Sepio Capital's portfolio in Q2 2026, its #6 holding.
  • Sepio Capital first reported a position in AbbVie in Q4 2018 and has held it in 20 quarters since.
  • Sepio Capital's AbbVie position peaked at $126M in Q4 2018.
  • 2,043 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.